Serum high mobility group box-1 and osteoprotegerin levels are associated with peripheral arterial disease and critical limb ischemia in type 2 diabetic subjects

被引:0
|
作者
Silvia Giovannini
Giovanni Tinelli
Federico Biscetti
Giuseppe Straface
Flavia Angelini
Dario Pitocco
Luciana Mucci
Raffaele Landolfi
Andrea Flex
机构
[1] A. Gemelli Foundation,Department of Gerontology and Geriatrics
[2] Catholic University of the Sacred Heart,Department of Vascular Surgery
[3] School of Medicine,Rheumatology and Affine Sciences Institute
[4] A. Gemelli Foundation,Laboratory of Vascular Biology and Genetics
[5] Catholic University of the Sacred Heart,Vascular Medicine and Atherothrombosis Laboratory, Department of Experimental Medicine
[6] School of Medicine,Department of Medicine
[7] A. Gemelli Foundation,undefined
[8] Catholic University of the Sacred Heart,undefined
[9] School of Medicine,undefined
[10] Catholic University School of Medicine,undefined
[11] Sapienza University of Rome,undefined
[12] A. Gemelli Foundation,undefined
[13] Catholic University School of Medicine,undefined
来源
Cardiovascular Diabetology | / 16卷
关键词
HMGB-1; OPG; PAD; Type 2 diabetes;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 2 条
  • [1] Serum high mobility group box-1 and osteoprotegerin levels are associated with peripheral arterial disease and critical limb ischemia in type 2 diabetic subjects
    Giovannini, Silvia
    Tinelli, Giovanni
    Biscetti, Federico
    Straface, Giuseppe
    Angelini, Flavia
    Pitocco, Dario
    Mucci, Luciana
    Landolfi, Raffaele
    Flex, Andrea
    CARDIOVASCULAR DIABETOLOGY, 2017, 16
  • [2] Fibroblast growth factor 23 serum level in type 2 diabetic italian subjects with peripheral arterial disease and critical limb ischemia
    Biscetti, F.
    Straface, G.
    Pitocco, D.
    Angelini, F.
    Tinelli, G.
    Landolfi, R.
    Flex, A.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2016, 20 (19) : 4048 - 4054